National survey on dyslipidemic patients - PRYSME

Study identifier:NIS-CFR-DUM-2007/9

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Survey on time to lipid-lowering drug implementation on dyslipidemic patients in general practice.

Medical condition

Dyslipidemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3655

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jun 2008
Primary Completion Date: -
Study Completion Date: 01 Jan 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2014 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria